Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 124 clinical trials
Featured trial
Heart Valve Disease – Aortic and Mitral

months, 1 year, 18 months, and annually through 10 years. Randomly assigned (50% to either group) Treatment of Aortic Stenosis with either Transcatheter Aortic Valve Replacement (TAVR) device or

aortic valve replacement
stenosis
  • 799 views
  • 05 Feb, 2021
  • 1 location
Featured trial
Low Risk TAVR-The purpose of this research study is to determine if replacing the aortic valve without open-heart surgery is as safe as or safer than open-heart surgery in patients who are considered at low risk for complications from surgery.

Low Risk TAVR-The purpose of this research study is to determine if replacing the aortic valve without open-heart surgery is as safe as or safer than open-heart surgery in patients who are considered at low risk for complications from surgery.

  • 534 views
  • 25 Mar, 2021
  • 1 location
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.

  • 0 views
  • 21 Jul, 2021
  • 1 location
Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis (BASELINE)

degenerated aortic bioprostheses in elderly patients3. The median time since index surgical aortic valve replacement (SAVR) and for bioprosthetic valve degeneration is typically 8 - 10 years4-6. TAVI in this

tavi
aortic valve replacement
stenosis
regurgitation
transcatheter aortic valve implantation
  • 1 views
  • 11 Aug, 2022
  • 1 location
Portico NG Approval Study

The purpose of this clinical study is to evaluate the acute safety and effectiveness of the next-generation Navitor (Portico™ NG) Transcatheter Aortic Heart Valve as assessed by the rate of all-cause mortality at 30 days and the rate of moderate or greater paravalvular leak at 30 days in a high …

  • 128 views
  • 20 Jul, 2022
  • 17 locations
TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium (TriRec)

Reconstruction of the aortic valve using the tri-leaflet repair technique is non-inferior with regard to effective orifice area (EOA) to surgical aortic valve replacement (SAVR) with a

  • 0 views
  • 05 Mar, 2022
  • 1 location
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF

transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF)

  • 0 views
  • 18 Apr, 2022
  • 1 location
The ShortCut™ Study Protocol

in patients who are presented for a valve-in-valve transcatheter aortic valve replacement (TAVR) procedure, and who are at risk for TAVR-induced coronary artery obstruction.

  • 0 views
  • 17 Mar, 2022
Evolut PRO China Clinical Study

stenosis (AS) who are at high risk for Surgical Aortic Valve Replacement (SAVR).

  • 0 views
  • 13 Mar, 2022
  • 3 locations
Sedation or General Anesthesia During TAVR (ANESTAVI)

Transcatheter aortic valve replacement TAVR is become the reference method for patients with severe aortic stenosis who are contraindicated or at risk for surgical aortic replacement. Initially

  • 0 views
  • 23 Mar, 2022
  • 2 locations